Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-10 Sale |
2022-05-12 4:18 pm |
Bausch & Lomb Corp | BLCO | Bausch Health Companies Inc. 10% Owner |
35,000,000 | $17.05 | $596,925,000 | 315,000,000 (Indirect) |
View |
| 2022-04-14 Sale |
2022-04-15 4:32 pm |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
1,595 | $22.19 | $35,393 | 90,506 (Direct) |
View |
| 2022-03-15 Sale |
2022-03-16 4:39 pm |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
4,846 | $22.2 | $107,581 | 92,101 (Direct) |
View |
| 2022-03-08 Sale |
2022-03-10 4:03 pm |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
3,889 | $21.76 | $84,625 | 93,139 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:58 pm |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
11,077 | $23.37 | $258,869 | 101,102 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:09 pm |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
1,595 | $23.37 | $37,275 | 232,931 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:29 pm |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
6,338 | $23.82 | $150,971 | 112,179 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-17 4:36 pm |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
3,251 | $25.02 | $81,340 | 60,299 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 7:55 pm |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
3,251 | $26.63 | $86,574 | 63,550 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-05-12 7:04 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Carson Seana EVP, General Counsel |
0 | $0 | 252,151 (Direct) |
View |
Ownership |
2022-05-12 2:13 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Vadaketh Tom George EVP, Chief Financial Officer |
0 | $0 | 491,353 (Direct) |
View |
Ownership |
2022-05-05 6:30 pm |
N/A N/A |
Bausch & Lomb Corp | BLCO | Bausch Health Companies Inc. 10% Owner |
0 | $0 | 350,000,000 (Indirect) |
View |
| 2022-05-03 Tax Withholding |
2022-05-05 4:12 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Munsch Frederick SVP, Controller and CAO |
747 | $18.66 | 22,435 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:13 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | WECHSLER AMY B Director |
300 | $22.85 | 99,354 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:08 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ROBERTSON RUSSEL C Director |
1,668 | $22.85 | 128,253 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:04 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Miller Steven D Director |
1,340 | $22.85 | 73,229 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 6:01 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ICAHN BRETT Director |
1,340 | $22.85 | 13,107 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 5:57 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | DE SCHUTTER RICHARD U Director |
1,504 | $22.85 | 334,892 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 5:53 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Paulson John Director |
1,340 | $22.85 | 86,629 (Direct) |
View |
| 2022-03-10 Tax Withholding |
2022-03-11 4:00 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL |
839 | $22.56 | 162,240 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:49 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
4,074 | $23.61 | 96,947 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:47 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Munsch Frederick SVP, Controller and CAO |
608 | $23.61 | 23,182 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:45 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL |
6,926 | $23.61 | 163,079 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:41 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Eldessouky Sam EVP & Chief Financial Officer |
1,242 | $23.61 | 119,455 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:34 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | PAPA JOSEPH C CHAIRMAN & CEO |
12,643 | $23.61 | 1,095,152 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:32 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
4,074 | $23.61 | 97,028 (Direct) |
View |
| 2022-03-03 Tax Withholding |
2022-03-07 5:30 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | APPIO THOMAS CEO, Pharma Business |
5,564 | $23.61 | 475,267 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:50 pm |
N/A 2032-03-02 |
Bausch Health Companies Inc. | BHC | APPIO THOMAS CEO, Pharma Business |
718,020 | $0 | 1,046,161 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:09 pm |
N/A 2032-03-02 |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
131,910 | $0 | 232,931 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:09 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
35,627 | $24.17 | 232,931 (Direct) |
View |
| 2022-02-27 Option Award |
2022-03-02 9:38 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | PAPA JOSEPH C Chairman & CEO |
208,231 | $0 | 1,107,795 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:38 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | PAPA JOSEPH C Chairman & CEO |
208,231 | $24.35 | 1,107,795 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 9:38 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | PAPA JOSEPH C Chairman & CEO |
5,115 | $24.06 | 1,107,795 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:38 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | PAPA JOSEPH C Chairman & CEO |
208,231 | $0 | 1,107,795 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:38 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | PAPA JOSEPH C Chairman & CEO |
126,740 | $24.35 | 1,107,795 (Direct) |
View |
| 2022-02-27 Option Award |
2022-03-02 9:29 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
17,350 | $0 | 112,179 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:29 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
17,350 | $24.35 | 112,179 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:29 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
17,350 | $0 | 112,179 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:29 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l |
9,471 | $24.35 | 112,179 (Direct) |
View |
| 2022-02-27 Option Award |
2022-03-02 9:12 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | APPIO THOMAS CEO, Pharma Business |
24,292 | $0 | 328,141 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:12 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | APPIO THOMAS CEO, Pharma Business |
24,292 | $24.35 | 328,141 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:12 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | APPIO THOMAS CEO, Pharma Business |
24,292 | $0 | 328,141 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:12 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | APPIO THOMAS CEO, Pharma Business |
13,376 | $24.35 | 328,141 (Direct) |
View |
| 2022-02-27 Option Award |
2022-03-02 9:08 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
15,615 | $0 | 66,989 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:08 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
15,615 | $24.35 | 66,989 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:08 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
15,615 | $0 | 66,989 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:08 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Spurr Robert U.S. President-Pharma Business |
8,925 | $24.35 | 66,989 (Direct) |
View |
| 2022-02-14 Option Award |
2022-03-02 9:06 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL |
24,292 | $0 | 170,005 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:06 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL |
24,292 | $24.35 | 170,005 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:06 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL |
24,292 | $0 | 170,005 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:06 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL |
16,028 | $24.35 | 170,005 (Direct) |
View |
| 2022-02-27 Option Award |
2022-03-02 9:01 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Munsch Frederick SVP, Controller and CAO |
3,330 | $0 | 23,790 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:01 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Munsch Frederick SVP, Controller and CAO |
3,330 | $24.35 | 23,790 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:01 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Munsch Frederick SVP, Controller and CAO |
3,330 | $0 | 23,790 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:01 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Munsch Frederick SVP, Controller and CAO |
1,958 | $24.35 | 23,790 (Direct) |
View |
| 2022-02-27 Option Award |
2022-03-02 9:00 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Eldessouky Sam EVP & Chief Financial Officer |
8,674 | $0 | 120,697 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:00 pm |
N/A 2022-02-27 |
Bausch Health Companies Inc. | BHC | Eldessouky Sam EVP & Chief Financial Officer |
8,674 | $24.35 | 120,697 (Direct) |
View |
| 2022-02-27 Exercise |
2022-03-02 9:00 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Eldessouky Sam EVP & Chief Financial Officer |
8,674 | $0 | 120,697 (Direct) |
View |
| 2022-02-27 Tax Withholding |
2022-03-02 9:00 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Eldessouky Sam EVP & Chief Financial Officer |
4,834 | $24.35 | 120,697 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:17 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | DE SCHUTTER RICHARD U Director |
1,245 | $27.61 | 333,388 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:16 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | WECHSLER AMY B Director |
249 | $27.61 | 99,054 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:14 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | ROBERTSON RUSSEL C Director |
1,380 | $27.61 | 126,585 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:12 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Paulson John Director |
1,109 | $27.61 | 85,289 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:10 pm |
N/A N/A |
Bausch Health Companies Inc. | BHC | Miller Steven D Director |
1,109 | $27.61 | 71,889 (Direct) |
View |